Rockefeller Capital Management L.P. Rocket Pharmaceuticals, Inc. Transaction History

Rockefeller Capital Management L.P.

$42.4 Billion
Q2 2025

A detailed history of Rockefeller Capital Management L.P. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 96,982 shares of RCKT stock, worth $331,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,982

Previous 96,982 -0.0%

Holding current value

$331,678

Previous $237,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$2.33 - $8.01 $15,331 - $52,705	6,580 Added 7.28%	96,982 $237,000
Q1 2025 May 14, 2025	BUY	$6.67 - $12.72 $12,252 - $23,366	1,837 Added 2.07%	90,402 $602,000
Q4 2024 Feb 13, 2025	SELL	$11.35 - $18.82 $219,588 - $364,110	-19,347 Reduced 17.93%	88,565 $1.11 Million
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $368,526 - $541,901	20,939 Added 24.08%	107,912 $1.99 Million
Q2 2024 Aug 12, 2024	BUY	$20.66 - $26.72 $31,217 - $40,373	1,511 Added 1.77%	86,973 $1.87 Million
Q1 2024 May 14, 2024	SELL	$26.16 - $30.74 $52 - $61	-2 Reduced -0.0%	85,462 $2.3 Million
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $107,392 - $204,416	-6,400 Reduced 6.97%	85,464 $2.56 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $146,932 - $234,487	9,750 Added 11.87%	91,864 $1.88 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $232,260 - $330,400	14,000 Added 20.55%	82,114 $1.63 Million
Q1 2023 May 17, 2023	BUY	$15.79 - $22.6 $331,590 - $474,600	21,000 Added 44.57%	68,114 $1.17 Million
Q4 2022 Mar 06, 2023	BUY	$15.5 - $22.76 $77,500 - $113,800	5,000 Added 11.87%	47,114 $921,000
Q3 2022 Nov 02, 2022	BUY	$12.37 - $18.41 $38,025 - $56,592	3,074 Added 7.87%	42,114 $671,000
Q2 2022 Aug 12, 2022	BUY	$7.96 - $16.64 $302 - $632	38 Added 0.1%	39,040 $537,000
Q1 2022 May 13, 2022	BUY	$13.16 - $23.68 $7,896 - $14,208	600 Added 1.56%	39,002 $618,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $542,304 - $907,704	25,200 Added 190.88%	38,402 $838,000
Q3 2021 Nov 12, 2021	BUY	$27.42 - $48.97 $361,998 - $646,501	13,202 New	13,202 $394,000
Q2 2021 Aug 10, 2021	SELL	$39.41 - $47.25 $91,825 - $110,092	-2,330 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $54,289 - $138,798	2,330 New	2,330 $127,000
Q3 2020 Nov 13, 2020	SELL	$20.5 - $28.59 $97,231 - $135,602	-4,743 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$9.71 - $25.11 $14,933 - $38,619	-1,538 Reduced 24.49%	4,743 $66,000
Q4 2019 Feb 07, 2020	SELL	$11.07 - $24.23 $885 - $1,938	-80 Reduced 1.26%	6,281 $143,000
Q3 2019 Nov 12, 2019	SELL	$10.85 - $14.78 $2,690 - $3,665	-248 Reduced 3.75%	6,361 $74,000
Q1 2019 May 10, 2019	BUY	$13.45 - $19.01 $6,725 - $9,505	500 Added 8.18%	6,609 $116,000
Q3 2018 Nov 02, 2018	BUY	$18.5 - $25.49 $113,016 - $155,718	6,109 New	6,109 $150,000

Others Institutions Holding RCKT

# of Institutions

222

Shares Held

98.5M

Call Options Held

611K

Put Options Held

474K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $259M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Rocket Pharmaceuticals, Inc. Transaction History